- Home
- CGEN vs APPS Comparison
CGEN vs APPS Comparison
Compare CGEN & APPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEN
- APPS
- Stock Information
- Founded
- CGEN 1993
- APPS 2007
- Country
- CGEN Israel
- APPS United States
- Employees
- CGEN N/A
- APPS N/A
- Industry
- CGEN Biotechnology: Biological Products (No Diagnostic Substances)
- APPS Multi-Sector Companies
- Sector
- CGEN Health Care
- APPS Miscellaneous
- Exchange
- CGEN Nasdaq
- APPS Nasdaq
- Market Cap
- CGEN 142.8M
- APPS 153.5M
- IPO Year
- CGEN 2000
- APPS N/A
- Fundamental
- Price
- CGEN $1.60
- APPS $1.43
- Analyst Decision
- CGEN Strong Buy
- APPS Hold
- Analyst Count
- CGEN 2
- APPS 4
- Target Price
- CGEN $4.00
- APPS $2.38
- AVG Volume (30 Days)
- CGEN 445.1K
- APPS 2.6M
- Earning Date
- CGEN 11-12-2024
- APPS 02-05-2025
- Dividend Yield
- CGEN N/A
- APPS N/A
- EPS Growth
- CGEN N/A
- APPS N/A
- EPS
- CGEN 0.02
- APPS N/A
- Revenue
- CGEN $59,852,000.00
- APPS $491,574,000.00
- Revenue This Year
- CGEN $57.27
- APPS N/A
- Revenue Next Year
- CGEN N/A
- APPS $9.20
- P/E Ratio
- CGEN $88.75
- APPS N/A
- Revenue Growth
- CGEN 698.03
- APPS N/A
- 52 Week Low
- CGEN $1.35
- APPS $1.18
- 52 Week High
- CGEN $3.03
- APPS $7.33
- Technical
- Relative Strength Index (RSI)
- CGEN 51.01
- APPS 38.47
- Support Level
- CGEN $1.55
- APPS $1.40
- Resistance Level
- CGEN $1.68
- APPS $1.48
- Average True Range (ATR)
- CGEN 0.08
- APPS 0.09
- MACD
- CGEN 0.01
- APPS 0.06
- Stochastic Oscillator
- CGEN 52.17
- APPS 27.08
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902, bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
About APPS Digital Turbine Inc.
Digital Turbine Inc is an independent mobile growth platform. It offers end-to-end products and solutions to all participants in the mobile application ecosystem, enabling brand discovery and advertising, user acquisition and engagement, and operational efficiency for advertisers. Its operating segments are On Device Solutions and App Growth Platform.